US Stock MarketDetailed Quotes

LTRN Lantern Pharma

Watchlist
  • 3.020
  • -0.125-3.97%
Close Dec 23 16:00 ET
  • 3.100
  • +0.080+2.65%
Post 16:18 ET
32.57MMarket Cap-1.70P/E (TTM)

About Lantern Pharma Company

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.

Company Profile

SymbolLTRN
Company NameLantern Pharma
Listing DateJun 11, 2020
Issue Price15.00
Founded2013
CEOMr. Panna L. Sharma
MarketNASDAQ
Employees21
Fiscal Year Ends12-31
Address1920 McKinney Avenue,7th floor
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75201
Phone1-972-277-1136
Websitehttp://www.lanternpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Panna L. Sharma
  • Chief Executive Officer, President and Director
  • 684.39K
  • Dr. Kishor G. Bhatia, PhD
  • Chief Scientific Officer
  • 283.24K
  • David R. Margrave
  • Principal Accounting Officer, Chief Financial Officer and Secretary
  • 442.68K
  • Donald Jeffrey Keyser
  • Chairman of the Board
  • 56.00K
  • David S. Silberstein
  • Director
  • 46.00K
  • Dr. Maria Maccecchini, PhD
  • Independent Director
  • 51.00K
  • Dr. Vijay Chandru
  • Independent Director
  • 46.00K
Heat List
US
Overall
Symbol
Price
% Chg

No Data